6 completed, 3 terminated, 1 active not recruiting, 1 enrolling by invitation. 13 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Completed 6, Terminated 3, Active not recruiting 1, Enrolling by invitation 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Enrolling by invitation 1, Terminated 1 |
Follow lonafarnib: new trials by email Literature Review of lonafarnib trials Research Report on lonafarnib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria Everolimus and lonafarnib - Progeria | Phase 1 / Phase 2 | Enrolling by invitation | Boston Children's Hospital | 80 | 2015-12-01 | 2026-04-02 |
| A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) Docetaxel plus lonafarnib - Prostate Cancer, Breast Cancer | Phase 1 / Phase 2 | Terminated | Merck Sharp & Dohme LLC | 5 | 2007-06-01 | 2015-02-05 |
| Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer Lonafarnib, Docetaxel - Lung Cancer, Soft Tissue Sarcoma | Phase 1 | Terminated | Emory University | 38 | 2006-01-01 | 2012-12-18 |
| PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas Temodar and SCH 66336 - Gliosarcoma, Glioblastoma | Phase 1 | Completed | Duke University | 37 | 2005-10-01 | 2013-02-20 |
| 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC) Fenretinide (4-HPR), SCH66336 - Head and Neck Cancer | Phase 1 | Terminated | M.D. Anderson Cancer Center | 1 | 2005-01-20 | 2018-11-15 |
| Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide Lonafarnib, Temozolomide - Malignant Supratentorial Neoplasm, Recurrent Glioblastoma | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 34 | 2004-12-21 | 2024-10-17 |
| Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas lonafarnib, temozolomide - Brain and Central Nervous System Tumors | Phase 1 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 30 | 2004-03-01 | 2015-02-10 |
| Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer trastuzumab, lonafarnib, paclitaxel - Breast Cancer | Phase 1 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 23 | 2003-08-01 | 2012-09-12 |
| Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec) - Chronic Myelogenous Leukemia | Phase 1 | Completed | M.D. Anderson Cancer Center | 23 | 2002-11-01 | 2018-11-07 |
| SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors lonafarnib - Brain and Central Nervous System Tumors | Phase 1 | Completed | Pediatric Brain Tumor Consortium | 53 | 2002-01-01 | 2009-10-14 |
| SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver SCH 66336, conventional surgery - Colorectal Cancer, Metastatic Cancer | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 1999-09-29 | 2018-11-14 | |
| A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer SCH66336 - Carcinoma, Squamous Cell, Cancer of Head and Neck | Phase 1 | Completed | M.D. Anderson Cancer Center | 37 | 1999-06-01 | 2018-10-30 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer fluorouracil, leucovorin calcium, lonafarnib - Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 25 | 1999-04-01 | 2013-04-04 |
Astrocytoma (3) · Breast Neoplasms (3) · Glioblastoma (3) · Gliosarcoma (3) · Oligodendroglioma (3) · Brain Neoplasms (2) · Central Nervous System Neoplasms (2) · Colorectal Neoplasms (2) · Glioma (2) · Head and Neck Neoplasms (2) · Lung Neoplasms (2) · Prostatic Neoplasms (2) · Breast Neoplasms, Male (1) · Burkitt Lymphoma (1) · Carcinoma, Squamous Cell (1)
M.D. Anderson Cancer Center (5) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Boston Children's Hospital (1) · Duke University (1) · Emory University (1) · Memorial Sloan Kettering Cancer Center (1) · Merck Sharp & Dohme LLC (1) · Pediatric Brain Tumor Consortium (1)
United States (9) · France (2) · Belgium (1) · Netherlands (1) · Switzerland (1)
Annick Desjardins, MD (1) · Edward S Kim, MD (1) · Jan H. M. Schellens, MD, PhD (1) · John Kauh, MD (1) · Jorge E. Cortes, MD (1) · Leonard B. Saltz, MD (1) · Mario Campone, MD (1) · Mark W. Kieran, MD, PhD (1) · Monica Kleinman, M.D. (1) · Steven A. Curley, MD (1) · Vinay Puduvalli (1)